Nutriband's AVERSA™ abuse-deterrent transdermal technology incorporates aversive agents into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse ...
Nutriband Inc. has successfully completed the scale-up of the commercial manufacturing process for its lead product, Aversa™ Fentanyl, in partnership with Kindeva, a contract development and ...
PharmaTher Enters Into Process Development Agreement With LTS LOHMANN for Ketamine Microneedle Patch
TORONTO and ANDERNACH, Germany, Dec. 20, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (“PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a company focused on the development and commercialization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback